Integra LifeSciences: Light At The End Of The Tunnel, Or Another Oncoming Train? (Rating Upgrade)

Core Viewpoint - Integra LifeSciences has faced significant challenges since mid-2023 due to quality control issues at its Boston plant, impacting growth in the Tissue Technologies business [1] Company Summary - The quality control issues have led to a decline in important growth drivers for Integra LifeSciences [1]